Latest news with #Catalist
Yahoo
13 hours ago
- Business
- Yahoo
If EPS Growth Is Important To You, Taka Jewellery Holdings (Catalist:42L) Presents An Opportunity
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should. So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Taka Jewellery Holdings (Catalist:42L). Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Taka Jewellery Holdings with the means to add long-term value to shareholders. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Fast Is Taka Jewellery Holdings Growing Its Earnings Per Share? In the last three years Taka Jewellery Holdings' earnings per share took off; so much so that it's a bit disingenuous to use these figures to try and deduce long term estimates. So it would be better to isolate the growth rate over the last year for our analysis. Taka Jewellery Holdings' EPS skyrocketed from S$0.015 to S$0.021, in just one year; a result that's bound to bring a smile to shareholders. That's a commendable gain of 42%. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. While we note Taka Jewellery Holdings achieved similar EBIT margins to last year, revenue grew by a solid 10.0% to S$159m. That's progress. In the chart below, you can see how the company has grown earnings and revenue, over time. To see the actual numbers, click on the chart. View our latest analysis for Taka Jewellery Holdings Taka Jewellery Holdings isn't a huge company, given its market capitalisation of S$70m. That makes it extra important to check on its balance sheet strength. Are Taka Jewellery Holdings Insiders Aligned With All Shareholders? Many consider high insider ownership to be a strong sign of alignment between the leaders of a company and the ordinary shareholders. So we're pleased to report that Taka Jewellery Holdings insiders own a meaningful share of the business. In fact, they own 90% of the company, so they will share in the same delights and challenges experienced by the ordinary shareholders. Intuition will tell you this is a good sign because it suggests they will be incentivised to build value for shareholders over the long term. To give you an idea, the value of insiders' holdings in the business are valued at S$64m at the current share price. That should be more than enough to keep them focussed on creating shareholder value! Does Taka Jewellery Holdings Deserve A Spot On Your Watchlist? You can't deny that Taka Jewellery Holdings has grown its earnings per share at a very impressive rate. That's attractive. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. Before you take the next step you should know about the 1 warning sign for Taka Jewellery Holdings that we have uncovered. There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of Singaporean companies which have demonstrated growth backed by significant insider holdings. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
CNA
a day ago
- Business
- CNA
Concert promoter Unusual apologises for inaccurate directors' remuneration disclosures in annual reports
SINGAPORE: Homegrown concert promoter Unusual on Tuesday (Jul 22) apologised for publishing wrong information about its directors' remuneration in two of its annual reports following queries from an investor group. For the financial year of 2024, the Catalist-listed firm had paid S$100,000 (US$78,198) in fees and S$1.7 million in incentives, among others, to its key management and board directors. However, remuneration disclosures in the year's annual report showed all its seven directors receiving less than S$250,000 each, when in fact Mr Leslie Ong and Mr Johnny Ong, the firm's two founders, earned above S$750,000 that year. In its latest annual report for 2025, the breakdown of compensation showed a header that said 'below S$250,000' despite some of its directors receiving total remuneration that exceeded that figure. Pointing out the discrepancies, the Securities Investors Association Singapore (SIAS), also asked why the firm had dished out S$1.7 million in directors' incentives in the year before a major loss and whether it was impacted by the troubles surrounding its major shareholder mm2 Asia. Unusual reported a net loss of S$22.5 million for the financial year of 2025, a reversal from profits of S$7.7 million in the previous year. In a filing to the Singapore Exchange on Jul 22, Unusual said 'the sub-headings in the tables showing the directors' remuneration were not correct in the company's annual reports'. It added that it had issued corrected figures of its directors' remuneration via a bourse filing on Jul 21, and apologised 'for any confusion that may arise'. 'Moving forward, we will take steps to strengthen the review and validation process to prevent such occurrences in the future,' said the firm, which was the concert promoter for Hong Kong Heavenly King Jacky Cheung's concert here in 2023 and most recently, Mandopop veteran Wakin Chau and Japanese pop legend Ayumi Hamasaki. On its financial losses, Unusual attributed this to several factors: a lower number of projects completed during the year; an increase in 'fair value loss on financial assets' due to the firm's decision to pivot away from certain genres in line with changing market conditions and evolving audience demand; as well as higher show fees and operational costs. Asked by SIAS if the awarding of S$1.7 million in directors' incentives in the year before a major loss may raise concerns about the company's governance and the integrity of its performance-based pay, Unusual said the incentives were 'determined based on performance metrics and contractual entitlements applicable at the time, taking into account the business environment and contributions made by the executive directors'. It added that the losses in 2025 were due to 'unexpected changes in the industry and broader operating conditions, which could not have been reasonably foreseen'. That said, the firm's board 'acknowledges that this may raise questions about perceived alignment between short-term incentives and long-term outcomes', and its remuneration committee 'will refine the remuneration structure to strengthen alignment with long-term performance'. This includes incorporating appropriate safeguards, performance conditions and accountability mechanisms to protect the interests of all shareholders, Unusual said. CONCERNS ABOUT MM2 Unusual, founded in 1997, counts entertainment firm mm2 Asia as its major shareholder. The latter owns 51 per cent of Unusual Management, which in turn holds 76.88 per cent of Unusual. Mainboard-listed mm2 Asia, which also owns Cathay Cineplexes, has been in the news for financial woes sparked by its struggling cinema operations. The entertainment firm has recently said it is mulling several options – including winding up the cinema business – to address its financial challenges. On whether mm2's financial issues have affected Unusual and what financial safeguards are in place, Unusual said that the issues presently faced by mm2 Asia 'is peculiar to itself and has nothing to do with the company'. The management of Unusual is also 'separate and independent' from mm2 Asia, it said. Mr Melvin Ang, founder and executive chairman of mm2 Asia, currently sits on the board of Unusual as an non-executive chairman and non-independent director. In response to further questions from SIAS, Unusual said that the group's recent pivot away from certain content genres, such as family-themed projects, was a 'commercially-driven or market-focused decision' that had nothing to do with mm2 Asia. On questions surrounding mm2 Asia's stake in the firm and whether Unusual's board would consider new strategic investors, the homegrown concert promoter replied that its board and directors has, from time to time, responded to 'queries from various parties, including possible strategic investors, on collaborations in various forms'. It added that it 'is open for discussion on any initiative(s) to bring the company and group to greater heights' but it would 'respectfully desist from making any comments on the possibilities and eventual outcome related to mm2 Asia's stake in the company'.
Yahoo
3 days ago
- Business
- Yahoo
If EPS Growth Is Important To You, TSH (Catalist:KUH) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up. So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like TSH (Catalist:KUH). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. TSH's Earnings Per Share Are Growing If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. TSH's shareholders have have plenty to be happy about as their annual EPS growth for the last 3 years was 54%. Growth that fast may well be fleeting, but it should be more than enough to pique the interest of the wary stock pickers. It's often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company's growth. TSH shareholders can take confidence from the fact that EBIT margins are up from 5.9% to 8.4%, and revenue is growing. Both of which are great metrics to check off for potential growth. In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image. View our latest analysis for TSH Since TSH is no giant, with a market capitalisation of S$4.3m, you should definitely check its cash and debt before getting too excited about its prospects. Are TSH Insiders Aligned With All Shareholders? Theory would suggest that it's an encouraging sign to see high insider ownership of a company, since it ties company performance directly to the financial success of its management. So we're pleased to report that TSH insiders own a meaningful share of the business. To be exact, company insiders hold 80% of the company, so their decisions have a significant impact on their investments. This makes it apparent they will be incentivised to plan for the long term - a positive for shareholders with a sit and hold strategy. Valued at only S$4.3m TSH is really small for a listed company. So despite a large proportional holding, insiders only have S$3.4m worth of stock. That's not a huge stake in absolute terms, but it should help keep insiders aligned with other shareholders. It means a lot to see insiders invested in the business, but shareholders may be wondering if remuneration policies are in their best interest. Our quick analysis into CEO remuneration would seem to indicate they are. Our analysis has discovered that the median total compensation for the CEOs of companies like TSH with market caps under S$257m is about S$479k. TSH offered total compensation worth S$331k to its CEO in the year to December 2024. That is actually below the median for CEO's of similarly sized companies. CEO compensation is hardly the most important aspect of a company to consider, but when it's reasonable, that gives a little more confidence that leadership are looking out for shareholder interests. It can also be a sign of a culture of integrity, in a broader sense. Is TSH Worth Keeping An Eye On? TSH's earnings per share growth have been climbing higher at an appreciable rate. An added bonus for those interested is that management hold a heap of stock and the CEO pay is quite reasonable, illustrating good cash management. The sharp increase in earnings could signal good business momentum. Big growth can make big winners, so the writing on the wall tells us that TSH is worth considering carefully. You still need to take note of risks, for example - TSH has 2 warning signs we think you should be aware of. Although TSH certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of Singaporean companies that not only boast of strong growth but have strong insider backing. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Investors in Versalink Holdings (Catalist:40N) have seen respectable returns of 35% over the past three years
It is doubtless a positive to see that the Versalink Holdings Limited (Catalist:40N) share price has gained some 39% in the last three months. But that doesn't help the fact that the three year return is less impressive. In fact, the share price is down 51% in the last three years, falling well short of the market return. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Versalink Holdings isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Shareholders of unprofitable companies usually desire strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit. Over the last three years, Versalink Holdings' revenue dropped 4.3% per year. That is not a good result. The share price decline of 15% compound, over three years, is understandable given the company doesn't have profits to boast of, and revenue is moving in the wrong direction. Of course, it's the future that will determine whether today's price is a good one. We'd be pretty wary of this one until it makes a profit, because we don't specialize in finding turnaround situations. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). This free interactive report on Versalink Holdings' balance sheet strength is a great place to start, if you want to investigate the stock further. A Dividend Lost It's important to keep in mind that we've been talking about the share price returns, which don't include dividends, while the total shareholder return does. In some ways, TSR is a better measure of how well an investment has performed. Over the last 3 years, Versalink Holdings generated a TSR of 35%, which is, of course, better than the share price return. Even though the company isn't paying dividends at the moment, it has done in the past. A Different Perspective Over the last year Versalink Holdings shareholders have received a TSR of 2.0%. Unfortunately this falls short of the market return of around 27%. But the (superior) three-year TSR of 10% per year is some consolation. We prefer focus on longer term returns, as they are usually a more meaningful indication of the underlying business. It's always interesting to track share price performance over the longer term. But to understand Versalink Holdings better, we need to consider many other factors. Take risks, for example - Versalink Holdings has 2 warning signs we think you should be aware of. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Business
- Yahoo
While individual investors own 22% of ISEC Healthcare Ltd. (Catalist:40T), public companies are its largest shareholders with 60% ownership
Key Insights ISEC Healthcare's significant public companies ownership suggests that the key decisions are influenced by shareholders from the larger public 60% of the company is held by a single shareholder (Aier Eye Hospital Group Co., Ltd.) Insider ownership in ISEC Healthcare is 15% This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To get a sense of who is truly in control of ISEC Healthcare Ltd. (Catalist:40T), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 60% to be precise, is public companies. Put another way, the group faces the maximum upside potential (or downside risk). Individual investors, on the other hand, account for 22% of the company's stockholders. Let's delve deeper into each type of owner of ISEC Healthcare, beginning with the chart below. See our latest analysis for ISEC Healthcare What Does The Institutional Ownership Tell Us About ISEC Healthcare? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. Less than 5% of ISEC Healthcare is held by institutional investors. This suggests that some funds have the company in their sights, but many have not yet bought shares in it. So if the company itself can improve over time, we may well see more institutional buyers in the future. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too. ISEC Healthcare is not owned by hedge funds. The company's largest shareholder is Aier Eye Hospital Group Co., Ltd., with ownership of 60%. This implies that they have majority interest control of the future of the company. Jun Shyan Wong is the second largest shareholder owning 4.8% of common stock, and CGS-CIMB Securities., Asset Management Arm holds about 2.8% of the company stock. Jun Shyan Wong, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known. Insider Ownership Of ISEC Healthcare While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our most recent data indicates that insiders own a reasonable proportion of ISEC Healthcare Ltd.. Insiders own S$30m worth of shares in the S$196m company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling. General Public Ownership With a 22% ownership, the general public, mostly comprising of individual investors, have some degree of sway over ISEC Healthcare. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. Public Company Ownership It appears to us that public companies own 60% of ISEC Healthcare. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership. Next Steps: While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for ISEC Healthcare you should know about. Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
